August 25, 2016Open Access

Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

ExoDOX is safer and more effective than free DOX. Importantly, the first spontaneous transformed syngeneic model of high-grade serous ovarian cancer was utilized for providing a new therapeutic opportunity.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Hadla et al. (Thu,) studied this question.

synapsesocial.com/papers/69d81ae852654bb436d18092 https://doi.org/https://doi.org/10.2217/nnm-2016-0154

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Integrated genomic analyses of ovarian carcinoma2011 · 8,166 citations
2ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer2015 · 133 citations
3Image-guided drug delivery: preclinical applications and clinical translation2015 · 46 citations
4Bio-inspired, bioengineered and biomimetic drug delivery carriers2011 · 1,221 citations
5Altering the immune response with lipid-based nanoparticles2011 · 139 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo